Trial for comparison of commonly used drug to the drug plus Calcium gluconate for measuring speed of recovery from muscle relaxant
Not Applicable
- Conditions
- Health Condition 1: K929- Disease of digestive system, unspecified
- Registration Number
- CTRI/2020/07/026726
- Lead Sponsor
- Armed Forces Medical Research Comittee
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1.Patients between age of 3 to 15 years
2.ASA I and II
Exclusion Criteria
1.Suspected difficult airway
2. History of bronchial asthma, neuromuscular disease, hepatic or renal disease.
3. Clinically suspected hypercalcemia
4. Severe or significant congenital heart disease
5.Bleeding diathesis
6.History of allergies to glycopyrrolate or neostigmine
7.Parental refusal
8. Weight of less than 10 kg.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Duration between injecting reversal agent and TOFr more than 90% <br/ ><br>Timepoint: 3,5 and 10 min
- Secondary Outcome Measures
Name Time Method Post operative Recurarisation at 3,5 and 10 min interval of giving the reversal agentTimepoint: 3,5 and 10 min